CIBC Asset Management
CTKB icon

CIBC Asset Management’s Cytek Biosciences CTKB Stock Holding History

CIBC Asset Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,100
Closed -$38.5K – 1378
2025
Q3 		$38.5K Hold
11,100
– – ﹤0.01% 1230
2025
Q2 		$37.7K Hold
11,100
– – ﹤0.01% 1208
2025
Q1 		$44.5K Sell
11,100
-311
-3% -$1.61K ﹤0.01% 1165
2024
Q4 		$74.1K Buy
11,411
+585
+5% +$3.48K ﹤0.01% 1192
2024
Q3 		$60K Buy
10,826
+466
+4% +$2.64K ﹤0.01% 1197
2024
Q2 		$57.8K Sell
10,360
-459
-4% -$2.76K ﹤0.01% 1128
2024
Q1 		$72.6K Hold
10,819
– – ﹤0.01% 1101
2023
Q4 		$98.7K Buy
+10,819
New +$68.1K ﹤0.01% 1055

Other funds holding CTKB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return